Daniel Spratt

63PUBLICATIONS

274CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRadiation therapyHaematological tumoursPacific Peoples tourism

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (63)

Sort by Publication Date:

|May 28, 2026

EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression.

|Apr 30, 2026

Trends in Long-Term Survival Among Patients With De Novo Metastatic Cancer.

|Apr 29, 2026

Real-world treatment patterns in patients with biochemical recurrence after local prostate cancer therapy.

|Feb 19, 2026

Apalutamide + Abiraterone Acetate plus Prednisone + Leuprolide with Stereotactic, Ultra-Hypofractionated Radiation in Very High-Risk Prostate Cancer: A Single-Arm, Phase 2 Study.

Sean M McBride, Daniel E Spratt, Marisa Kollmeier

|Dec 20, 2025

Association of race and survival in patients treated with apalutamide: Pooled analysis of two phase 3 trials.

Georges Gebrael, Neeraj Agarwal, Alicia K Morgans

|Dec 16, 2025

Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer.

Soumyajit Roy, Yilun Sun, Maha Hussain

Pageof 11

Frequent Collaborators

10 joint publications

Robert T Dess

Randy Vince

Felix Y Feng

Amar U Kishan

Soumyajit Roy

Todd Morgan

Yilun Sun

Angela Y Jia

Nicholas G Zaorsky

William C Jackson

Frequent Collaborators

10 joint publications

Robert T Dess

9 joint publications

Randy Vince

9 joint publications

Felix Y Feng

9 joint publications

Amar U Kishan